CONFERENCE PROGRAMME

Day 1, Monday, 7 December 2015 (Andaman Grand Ballroom)

TIME

PROGRAM

PRESENTER

08:00 : 09:00

Registration

(Conference Secretariat, Andaman Grand Ballroom Foyer)

 
 

SESSION 1: CONGENITAL HYPOTHYROID

Chairpersons: Dr Dianne Webster & Dr Ngu Lock Hock

09:00 – 09:30

Newborn screening for congenital hypothyroidism in the Asia Pacific region and challenges in developing countries

 

09:30 – 10:00

Congenital hypothyroidism screening in Malaysia – From the Drawing Board to Implementation

Dr Aminah Bee Mohd Kassim/

Dr Muhammad Arif Hashim

(Malaysia)

10:00 – 1030

Tea Break/Booth visit/Poster viewing

 

10:30 – 11:30

PLENARY 1 – New insights into Newborn Screening

Chairperson: Dr Thong Meow Keong

Dr Veronica Wiley (Australia)

 

SESSION 2 : COUNTRY REPORTS

 
 

A:  Developed Countries

Chairpersons: Dr Ngu Lock Hock & Dr Hans Amin Rostenberghe

11:30 – 11:36

-          Taiwan

Dr Yin-Hsiu Chien

11:36 – 11:42

-          Japan

Dr Seiji Yamaguchi

11:42 – 11:48

-          Australia

Dr Veronica Wiley

11:48 – 11:54

-          Singapore

Dr Tan Ee-Shien

11:54 – 12:00

-          New Zealand

Dr Dianne Webster

 

B:  Developing Countries

Chairpersons: Dr Julia Omar & Dr See Kwee Ching

12:00 – 12:06

-          China

Dr Zhengyan Zhao

12:06 – 12:12

-          Philippines

Dr Carmencita Padilla

12:12 – 12:18

-          India

Dr Seema Kapoor

12:18 – 12:24

-          Indonesia

Dr Diet Sadiah Rustama

12:24 – 12:30

-          Malaysia

Dr Aminah Bee Mohd Kassim

12: 30 – 12:36

-          Thailand

Dr Pornswan Wasant

12:36 – 13:00

Q & A

 

13:00 – 14:00

Lunch (Tamarind Brasserie)

 

14:00 -14:30

Arrival of guest (Opening Ceremony)

 

14:30 – 15:00

Welcome Speech & Opening Ceremony YBhg. Professor Dato’ Dr Muhammad Jantan, Deputy Vice-Chancellor Research & Innovation, Universiti Sains Malaysia

15:00 – 15:30

KEYNOTE LECTURE – Newborn  Screening in Malaysia: Past, Present and Future

To’ Puan Dr Safura Jaafar, Director, Family Health Development, Ministry of Health Malaysia

15:30 – 16:00

Tea Break/Booth visit/Poster viewing

16:00 – 17:40

FREE PAPER SESSION

Chairperson : Dr Aminah Bee Mohd Kassim & Dr Rowani Mohd Rawi

 

Further expansion of the neonatal screening panel in the Netherlands

Dr Gerard Loeber (Netherlands)

High risk screening of inherited metabolic disease by LC-MS/MS: Malaysian experience and challenges

Dr Anasufiza Habib (Malaysia)

Neonatal screening for PKU in Beijing

Dr Jin-Qi Zhao (China)

Newborn screening vs high risk screening in India in a tertiary care pediatric hospital in Andhra Pradesh, South India

Dr Akella Radha Rama Devi (India)

Glucose 6-phosphate dehydrogenase (G6PD) enzyme deficiency detected in newborn screening: a North India experience

Dr Kirti Sighal (India)

20:00

Conference Welcome Dinner Andaman Grand Ballroom

                                                                     END OF DAY 1

Day 2, Tuesday, 8 December 2015 (Andaman Grand Ballroom)

TIME

TOPIC

PRESENTER

08:00 : 09:00

PLENARY 2 – Newborn screening experiences worldwide and barriers to be overcome in establishing sustainable screening systems in developing countries

Chairperson: Dr Veronica Wiley

Dr Bradford L Therrell (USA)

 

SESSION 3: NATIONAL NEWBORN SCREENING PROGRAMME

Chairpersons: Dr Salina Abdul Rahman & Dr Adi Tan

09:00 – 09:30

LSD newborn screening: sharing experiences. Taiwan experience

Dr Yin-Hsui Chien (Taiwan)

09:30 – 10:00

Congenital Adrenal Hyperplasia Screening in Japan

Dr Kenichi Kashimada (Japan)

10:00 – 10:30

National Newborn Screening Program- Challenges and Future Plans

Dr Seema Kapoor (India)

10:30 – 11:00

Newborn Screening for hearing loss in Malaysia: Are we hearing it?

Ms Nur Azyani Amri (Malaysia)

11:00 – 11:30

Tea Break/Booth visit/Poster viewing

 

SESSION 4: G6PD DEFICIENCY

Chairpersons: Dr Gerard Loeber & Dr Julia Omar

11:30 – 12:00

G6PD deficiency screening: External quality assurance program issues

Dr Hsiao Kwang Jen (Taiwan)

12:00 – 12:30

G6PD deficiency in Malaysia – Are we missing our G6PD deficient babies?

Dr Boo Yen Num (Malaysia)

Dr Muhammad Arif Hashim (Malaysia)

12:30 – 14:00

Lunch (Tamarind Brasserie)

 

SESSION 5: EXPANDED NEWBORN SCREENING PROGRAMME – HARMONIZATION ISSUES

Chairpersons: Dr Carmencita Padilla & Dr Boo Nem Yun

14:00 – 14:30

CLSI terminology harmonisation project

Dr Dianne Webster (New Zealand)

14:30 – 15:00

Two decades of newborn screening for sickle cell diseases in the United States and a new related CLSI Project

Dr Bradford L Therrell (USA)

15:00 – 15:30

Expanded newborn screening of inborn error of metabolism in neonatal dried blood spots using Tandem Mass Spectrometry (TMS) in Malaysia

Dr Salina Abdul Rahman (Malaysia)

 

Subclinical disorders: Dilemma and challenges

15:30 – 15:45

Neuropsychological outcomes in children with subclinical congenital hypothyroidism

Dr Natasha Heather (New Zealand)

15:45 – 16:00

Association between newborn bloodspot thyroid stimulating hormone and educational and development outcomes

Dr Veronica Wiley (Australia)

16:00 – 16:30

Tea Break/Booth visit/Poster viewing

16:30 -18:30

FREE PAPER SESSION

Chairpersons: Dr Seema Kapoor & Dr Hsiao Kwang Jen

 

Strategy for newborn screening of methylmalonic/propionic acidemias using MS/MS and LC-MS/MS

Dr Yosuke Shigematsu (Japan)

Applying key performance indicators to evaluate and improve newborn screening system: The example of the Saudi newborn screening program

Dr Zuhair Al-Hassnan (Saudi Arabia)

Prenatal diagnosis for severe forms of organic acidemias and fatty acid oxidation defects which are targets of expanded newborn screening

Dr Seiji Yamaguchi (Japan)

Clinical and metabolic profile of neonatal encephalopathy

Dr Kirti Sighal (India)

High risk screening for biotinidase deficiency

Dr. Yin-Hsiu Chien (Taiwan)

Newborn screening for aromatic 1-amino acid decarboxylase deficiency

Dr Pin-Wen Chen (Taiwan

Newborn screening for spinal muscular atrophy

Dr Yin-Hsiu Chien (Taiwan)

The cardiac manifestations of genetically homogenous very-long-chain acyl-coa dehydrogenase deficiency and the outcome of early intervention following newborn screening

Dr Zuhair Al-Hassnan (Saudi Arabia)

Hyperphenylalaninemia detected in newborn screening by tandem mass spectrometry (MS/MS)

Dr James Lim (Singapore)

                                                                       END OF DAY 2

Day 3, Wednesday, 9 December 2015 (Andaman Grand Ballroom)

TIME

TOPIC

PRESENTER

08:00 : 09:00

PLENARY 3 – Paradigm shift in newborn screening: The molecular approach

Chairperson: Dr Thong Meow Keong

Dr Suzanne Cordovado (USA)

 

SESSION 6: NEWBORN SCREENING PATHWAYS

Chairpersons: Dr Diet Sadiah Rustama & Dr Hans Amin Rostenberghe

09:00 – 09:30

Approach to minimise False Positive and False Negatives

Dr Veronica Wiley (Australia)

09:30 – 10:00

Current state of molecular testing in public health laboratories: The US Experience

Dr Suzanne Cordovado (USA)

10:00 – 10:30

Issues and challenges in laboratory practices in Malaysia: The private practitioners’ perspective

Dr Adi Tan (Malaysia)

10:30 – 11:00

Can a little red beam of light save newborn lives?

Ms Annamarie Saarinen (USA)

11:00 – 12:00

FREE PAPER SESSION

Chairpersons: Dr Rowani Mohd Rawi & Dr Anasufiza Habib

 

Efforts for establishing newborn screening program for congenital hypothyroidism in Lahore - Pakistan

Dr Farkhanda Ghafoor (Pakistan)

Neurodevelopmental outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring

Dr Natasha Heather (New Zealand)

A new screening protocol for congenital hypothyroidism evaluated

Dr Natasha Heather (New Zealand)

Evaluation of a screening program for congenital hypothyroidism of thyroidal as well as of central origin in the Netherlands

Dr Paul Verkerk (Netherlands)

The severity of congenital hypothyroidism  of thyroidal and of central origin

Dr Paul Verkerk (Netherlands)

12:00 – 13:00

Closing ceremony

                                                                   END OF CONFERENCE

SPONSORS

sponsors